Pek‐Lan Khong

9.4k total citations · 3 hit papers
149 papers, 6.4k citations indexed

About

Pek‐Lan Khong is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Pek‐Lan Khong has authored 149 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Radiology, Nuclear Medicine and Imaging, 26 papers in Oncology and 24 papers in Pathology and Forensic Medicine. Recurrent topics in Pek‐Lan Khong's work include Radiomics and Machine Learning in Medical Imaging (26 papers), Advanced Neuroimaging Techniques and Applications (23 papers) and MRI in cancer diagnosis (19 papers). Pek‐Lan Khong is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (26 papers), Advanced Neuroimaging Techniques and Applications (23 papers) and MRI in cancer diagnosis (19 papers). Pek‐Lan Khong collaborates with scholars based in Hong Kong, China and United States. Pek‐Lan Khong's co-authors include Bingsheng Huang, Martin Law, Elaine Lee, Deqiang Qiu, Yok‐Lam Kwong, Gaik‐Cheng Ooi, Silun Wang, Lucullus H.T. Leung, EX Wu and Queenie Chan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Pek‐Lan Khong

146 papers receiving 6.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Imaging Profile of the COVID-19 Infection: Radiologic Findings and Literature Review

2020 743 citations Elaine Lee, Pek‐Lan Khong et al. profile →
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase

2017 359 citations Yok‐Lam Kwong, Thomas S. Y. Chan et al. profile →
Medical imaging and nuclear medicine: a Lancet Oncology Commission

2021 161 citations Pek‐Lan Khong et al. profile →

Peers

Countries citing papers authored by Pek‐Lan Khong

Since Specialization

Citations

This map shows the geographic impact of Pek‐Lan Khong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pek‐Lan Khong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pek‐Lan Khong more than expected).

Fields of papers citing papers by Pek‐Lan Khong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pek‐Lan Khong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pek‐Lan Khong. The network helps show where Pek‐Lan Khong may publish in the future.

Co-authorship network of co-authors of Pek‐Lan Khong

This figure shows the co-authorship network connecting the top 25 collaborators of Pek‐Lan Khong. A scholar is included among the top collaborators of Pek‐Lan Khong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pek‐Lan Khong. Pek‐Lan Khong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic PET [11C]-acetate uptake is associated with hypoxia gene expression in patients with late-stage hepatocellular carcinoma – a bench to bed study 2024 ·Cancer Imaging ·K.W. Chiu, Kel Vin Tan, (unknown), Xiaoqiang Zhu, (unknown), Chi‐Leung Chiang, Lawrence Chan, Hui Yuan, Pek‐Lan Khong, Kwan Man, Jason W.H. Wong	2
2	Epigenetics in Heart Failure 2024 ·International Journal of Molecular Sciences ·Jamie Sin Ying Ho, Eric Jou, Pek‐Lan Khong, Roger Foo, Ching‐Hui Sia	6
3	Targeted Radionuclide Therapy in Glioblastoma 2024 ·ACS Applied Materials & Interfaces ·Xiaobin Zhao, (unknown), (unknown), Tianzhi Zhao, Jingyan Wang, Pek‐Lan Khong, Xiaoyuan Chen, Jingjing Zhang	9
4	TPI1‐reduced extracellular vesicles mediated by Rab20 downregulation promotes aerobic glycolysis to drive hepatocarcinogenesis 2021 ·Journal of Extracellular Vesicles ·Bonnie Hei Man Liu, Sze Keong Tey, Xiaowen Mao, (unknown), Cherlie Lot Sum Yeung, Samuel W. K. Wong, (unknown), Yi Xu, Yue Yao, (unknown), Kel Vin Tan, Pek‐Lan Khong, Daniel Wai‐Hung Ho, Irene Oi‐Lin Ng, (unknown), Shaohang Cai, Jing‐Ping Yun, Judy Wai Ping Yam	38
5	Low‐dose pembrolizumab and nivolumab were efficacious and safe in relapsed and refractory classical Hodgkin lymphoma: Experience in a resource‐constrained setting 2020 ·Hematological Oncology ·Thomas S. Y. Chan, Yu‐Yan Hwang, Pek‐Lan Khong, Anskar Y.H. Leung, Chor Sang Chim, Eric Tse, Yok‐Lam Kwong	23
6	Radiomics Model to Predict Early Progression of Nonmetastatic Nasopharyngeal Carcinoma after Intensity Modulation Radiation Therapy: A Multicenter Study 2019 ·Radiology Artificial Intelligence ·Richard Du, Victor Lee, Hui Yuan, Ka-On Lam, Herbert Pang, (unknown), Edmund Y. Lam, Pek‐Lan Khong, Anne W.M. Lee, Dora L.�W. Kwong, Varut Vardhanabhuti	46
7	CRAF Methylation by PRMT6 Regulates Aerobic Glycolysis–Driven Hepatocarcinogenesis via ERK‐Dependent PKM2 Nuclear Relocalization and Activation 2019 ·Hepatology ·Tin Lok Wong, Kai‐Yu Ng, Kel Vin Tan, (unknown), Lei Zhou, Noélia Che, Ruby L.C. Hoo, Terence K. Lee, Stéphane Richard, Chung Mau Lo, Kwan Man, Pek‐Lan Khong, Stephanie Ma	91
8	Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes 2019 ·British Journal of Cancer ·John M. Nicholls, Victor Lee, (unknown), (unknown), Cheuk‐Wai Choi, Dora Lai‐Wan Kwong, Ka-On Lam, Sum‐Yin Chan, Chi‐Chung Tong, (unknown), To‐Wai Leung, Mai‐Yee Luk, Pek‐Lan Khong, Anne W.M. Lee	25
9	Short Version Dental Anxiety Inventory Score May Predict the Response in the Insular Cortex to Stimuli Mimicking Dental Treatment 2019 ·Frontiers in Human Neuroscience ·Andy Wai Kan Yeung, (unknown), Hiroki C. Tanabe, Sam K. S. Ng, Pek‐Lan Khong, WK Leung, Tazuko K. Goto	6
10	Negative Affect Shared with Siblings is Associated with Structural Brain Network Efficiency and Loneliness in Adolescents 2019 ·Neuroscience ·Nichol M. L. Wong, Robin Shao, (unknown), Pek‐Lan Khong, Edward S. Hui, C. Mary Schooling, GM Leung, Tatia M.C. Lee	8
11	The addition of pretreatment plasma Epstein–Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification 2018 ·International Journal of Cancer ·Victor Lee, Dora Lai‐Wan Kwong, To‐Wai Leung, Cheuk‐Wai Choi, Brian O’Sullivan, Ka‐On Lam, Vincent Lai, Pek‐Lan Khong, (unknown), (unknown), Chi‐Chung Tong, Patty Ho, Wing‐Lok Chan, Lai‐San Wong, (unknown), Sum‐Yin Chan, (unknown), Mai‐Yee Luk, Anne W.M. Lee	80
12	PET/CT in the evaluation of treatment response to neoadjuvant chemoradiotherapy and prognostication in patients with locally advanced esophageal squamous cell carcinoma 2016 ·Nuclear Medicine Communications ·Hui Yuan, Daniel King Hung Tong, Varut Vardhanabhuti, Simon Law, K.W. Chiu, Pek‐Lan Khong	13
13	Metabolic Phenotype of Stage IV Lung Adenocarcinoma 2015 ·Clinical Nuclear Medicine ·Elaine Lee, Pek‐Lan Khong, Victor Lee, (unknown), Xue‐Zhong Yu, Maria Pik Wong	30
14	Lateralization of the arcuate fasciculus and its differential correlation with reading ability between young learners and experienced readers: A diffusion tensor tractography study in a chinese cohort 2011 ·Human Brain Mapping ·Deqiang Qiu, Li‐Hai Tan, Wai Ting Siok, Ke Zhou, Pek‐Lan Khong	28
15	Utility of 18F‐FDG PET/CT in identifying terminal ileal myeloid sarcoma in an asymptomatic patient 2011 ·American Journal of Hematology ·Elaine Lee, Anskar Y.H. Leung, (unknown), Florence Loong, Pek‐Lan Khong	4
16	Quantitative Assessment of Diffusion-Weighted MR Imaging in Patients with Primary Rectal Cancer: Correlation with FDG-PET/CT 2010 ·Molecular Imaging and Biology ·(unknown), Pek‐Lan Khong, Silun Wang, Queenie Chan, Wai‐Lun Law, Jingbo Zhang	74
17	Pattern of Arterial Calcification in Patients with Systemic Lupus Erythematosus 2009 ·The Journal of Rheumatology ·Kai‐Hang Yiu, Silun Wang, Mo-Yin Mok, G.C. Ooi, Pek‐Lan Khong, (unknown), Kwok–Fai Lam, Chak Sing Lau, Hung‐Fat Tse	45
18	MRI of late microstructural and metabolic alterations in radiation‐induced brain injuries 2009 ·Journal of Magnetic Resonance Imaging ·Kevin C. Chan, Pek‐Lan Khong, Matthew M. Cheung, Silun Wang, (unknown), EX Wu	67
19	Congenital abdominal aortic aneurysm and renal dysplasia 2004 ·Pediatric Radiology ·(unknown), Pek‐Lan Khong, (unknown), Constantine Metreweli	7
20	Fast-flow lingual vascular anomalies in the young patient: is imaging diagnostic? 2003 ·Pediatric Radiology ·Pek‐Lan Khong, Patricia E. Burrows, Harry P. Kozakewich, John B. Mulliken	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact